Recent Updates
Recently added Catalysts
ELAN Negative Sentiment Score: 25/100

Elanco Animal Health Incorporated Class Action: The Gross Law Firm Reminds Elanco Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 6, 2024 – ELAN

Key Takeaway: Elanco Animal Health Incorporated is facing a class action lawsuit alleging that the company issued misleading statements regarding its product Zenrelia and overstated its financial prospects. The allegations include that Zenrelia, intended for canine dermatology, was less safe than advertised and that Elanco is unlikely to meet previously stated timelines for product approvals. Shareholders affected during the defined class period from November 7, 2023, to June 26, 2024, are encouraged to register for participation by December 6, 2024.

Market Sentiment Analysis

CONCERNS & RISKS

  • Allegations suggest that Elanco misrepresented the safety of Zenrelia.
  • Concerns raised over Elanco's inability to meet product launch timelines.
  • Company's financial prospects were allegedly overstated.
  • Public statements from Elanco are claimed to be materially false and misleading.

Full Press Release Details

NEW YORK, Nov. 20, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Elanco Animal Health Incorporated (NYSE: ELAN).
Shareholders who purchased shares of ELAN during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.
CLASS PERIOD: November 7, 2023 to June 26, 2024
ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) Zenrelia, a once-daily oral inhibitor for canine dermatology, was less safe than the Company had led investors to believe; (ii) Elanco was unlikely to meet its own previously issued timeline for the U.S. approval and commercial launch of both Zenrelia and Credelio Quattro, a broad spectrum parasiticide product for dogs; (iii) accordingly, the Company’s business and/or financial prospects were overstated; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.
DEADLINE: December 6, 2024 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/elanco-animal-health-incorporated-loss-submission-form/?id=112579&from=3
NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of ELAN during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is December 6, 2024. There is no cost or obligation to you to participate in this case.
WHY GROSS LAW FIRM? The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a company lead to artificial inflation of the company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.
15 West 38th Street, 12th floor
Phone: (646) 453-8903

Tags

Frequently Asked Questions

What is the class period for Elanco Animal Health shareholders?

The class period for shareholders is from November 7, 2023, to June 26, 2024.

What key allegations are made against Elanco?

The allegations include false safety claims about Zenrelia and overstated financial prospects.

Is lead plaintiff appointment necessary for recovery?

No, shareholders do not need to be appointed lead plaintiff to recover.

What is the deadline for shareholders to register?

The deadline to register is December 6, 2024.

How can shareholders stay updated on the case status?

Registered shareholders will receive updates via portfolio monitoring software.

Last updated: Nov 20, 2024